Citadel Advisors’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $459K | Buy |
+185,272
| New | +$459K | ﹤0.01% | 4153 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5962 |
|
|
2024
Q4 | – | Sell |
-703,704
| Closed | -$3.06M | – | 5986 |
|
|
2024
Q3 | $3.06M | Buy |
703,704
+699,175
| +15,438% | +$3.04M | ﹤0.01% | 2143 |
|
|
2024
Q2 | $21.1K | Sell |
4,529
-6,557
| -59% | -$30.6K | ﹤0.01% | 5388 |
|
|
2024
Q1 | $56.2K | Sell |
11,086
-109,679
| -91% | -$556K | ﹤0.01% | 5293 |
|
|
2023
Q4 | $339K | Buy |
120,765
+101,994
| +543% | +$287K | ﹤0.01% | 4119 |
|
|
2023
Q3 | $53.9K | Sell |
18,771
-1,196,637
| -98% | -$3.43M | ﹤0.01% | 5060 |
|
|
2023
Q2 | $6.14M | Buy |
1,215,408
+657,637
| +118% | +$3.32M | ﹤0.01% | 1559 |
|
|
2023
Q1 | $1.05M | Sell |
557,771
-216,027
| -28% | -$408K | ﹤0.01% | 3125 |
|
|
2022
Q4 | $1.39M | Buy |
773,798
+733,149
| +1,804% | +$1.32M | ﹤0.01% | 2911 |
|
|
2022
Q3 | $69K | Sell |
40,649
-45,295
| -53% | -$76.9K | ﹤0.01% | 5220 |
|
|
2022
Q2 | $211K | Buy |
85,944
+42,856
| +99% | +$105K | ﹤0.01% | 4959 |
|
|
2022
Q1 | $119K | Buy |
43,088
+491
| +1% | +$1.36K | ﹤0.01% | 5551 |
|
|
2021
Q4 | $227K | Buy |
42,597
+971
| +2% | +$5.17K | ﹤0.01% | 5380 |
|
|
2021
Q3 | $352K | Buy |
41,626
+11,445
| +38% | +$96.8K | ﹤0.01% | 4883 |
|
|
2021
Q2 | $368K | Buy |
30,181
+13,062
| +76% | +$159K | ﹤0.01% | 5005 |
|
|
2021
Q1 | $415K | Buy |
+17,119
| New | +$415K | ﹤0.01% | 4726 |
|